Skip to main content
Signal8

Ferguson Merle

SEC insider (Form 3/4/5 filer). CIK 0001749860. Director at BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH). 3 reported Form 4/5 transactions since Sep 2024; latest on Apr 22, 2026. Located in ENCINITAS, CA.

Companies Ferguson Merle has filed insider reports for

  • BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH): Director
Ferguson Merle profile photo

Ferguson Merle

CIK: 0001749860

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BIOFORCE NANOSCIENCES HOLDINGS, INC. logo
BFNH

BIOFORCE NANOSCIENCES HOLDINGS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • BIOFORCE NANOSCIENCES HOLDINGS, INC. logo
    BFNH

    BIOFORCE NANOSCIENCES HOLDINGS, INC.

    Apr 22, 2026
    Sale
    Direct
    26.7M shares at avg. $0.01$401K
  • BIOFORCE NANOSCIENCES HOLDINGS, INC. logo
    BFNH

    BIOFORCE NANOSCIENCES HOLDINGS, INC.

    Apr 20, 2026
    Gift
    Direct
    20.6M shares at avg. $0.01$144K
  • BIOFORCE NANOSCIENCES HOLDINGS, INC. logo
    BFNH

    BIOFORCE NANOSCIENCES HOLDINGS, INC.

    Apr 20, 2026
    Gift
    Direct
    4.1M shares at avg. $0.00$4K

1-3 of 3